Literature DB >> 30336990

Lewy Body Dementia.

Angela M Sanford1.   

Abstract

Dementia with Lewy bodies (DLB) is the second most common neurodegenerative dementia following Alzheimer disease. It stems from the formation of Lewy bodies, which contain aggregates of the misfolded protein, α-synuclein. These deposit in areas of the nervous system and brain, leading to neuronal cell death and causing clinically apparent symptoms. Because of its clinical overlap with other forms of dementia, DLB is often underdiagnosed and misdiagnosed. There is currently no cure for DLB and treatments are aimed at ameliorating specific symptoms.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dementia; Dementia with Lewy bodies; Lewy body dementia; Parkinson’s disease with dementia; Synucleinopathy

Mesh:

Substances:

Year:  2018        PMID: 30336990     DOI: 10.1016/j.cger.2018.06.007

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  11 in total

Review 1.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

2.  Caregiver Support in a Case of Posttraumatic Stress Disorder and Lewy Body Dementia.

Authors:  Aaron A Kuntz; Ellen Wanninger; Brian Lewis
Journal:  Fed Pract       Date:  2022-05-13

Review 3.  Modeling Neurodegenerative Diseases Using In Vitro Compartmentalized Microfluidic Devices.

Authors:  Louise Miny; Benoît G C Maisonneuve; Isabelle Quadrio; Thibault Honegger
Journal:  Front Bioeng Biotechnol       Date:  2022-06-24

4.  Metabolic Network Topology of Alzheimer's Disease and Dementia with Lewy Bodies Generated Using Fluorodeoxyglucose Positron Emission Tomography.

Authors:  Masamichi Imai; Mika Tanaka; Muneyuki Sakata; Kei Wagatsuma; Tetsuro Tago; Jun Toyohara; Renpei Sengoku; Yuji Nishina; Kazutomi Kanemaru; Kenji Ishibashi; Shigeo Murayama; Kenji Ishii
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

5.  Validation of the National Alzheimer's Coordinating Center (NACC) Lewy Body Disease Module neuropsychological tests.

Authors:  Annalise Rahman-Filipiak; Shima Sadaghiyani; Katrail Davis; Arijit K Bhaumik; Henry L Paulson; Bruno Giordani; Benjamin M Hampstead
Journal:  Alzheimers Dement (Amst)       Date:  2022-02-09

6.  Treadmill exercise reduces α-synuclein spreading via PPARα.

Authors:  Debashis Dutta; Ramesh Kumar Paidi; Sumita Raha; Avik Roy; Sujyoti Chandra; Kalipada Pahan
Journal:  Cell Rep       Date:  2022-07-12       Impact factor: 9.995

Review 7.  Neuroimaging in Dementia With Lewy Bodies.

Authors:  Abhishikta Saha; Dipanjan Banerjee
Journal:  Cureus       Date:  2021-06-16

8.  Promising Molecular Targets for Pharmacological Therapy of Neurodegenerative Pathologies.

Authors:  M E Neganova; Yu R Aleksandrova; V O Nebogatikov; S G Klochkov; A A Ustyugov
Journal:  Acta Naturae       Date:  2020 Jul-Sep       Impact factor: 1.845

9.  Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF.

Authors:  Walter A Boiten; Inger van Steenoven; Mei-Fang Xiao; Paul F Worley; Barbara Noli; Cristina Cocco; Gian-Luca Ferri; Afina W Lemstra; Charlotte E Teunissen
Journal:  Cells       Date:  2020-12-29       Impact factor: 6.600

10.  Cardiac Alpha-Synuclein Is Present in Alpha-Synucleinopathies.

Authors:  Keivan Javanshiri; Tove Drakenberg; Mattias Haglund; Elisabet Englund
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.